BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25167201)

  • 1. α-Fetoprotein assay on dried blood spot for hepatoblastoma screening in children with overgrowth-cancer predisposition syndromes.
    Mussa A; Pagliardini S; Pagliardini V; Molinatto C; Baldassarre G; Corrias A; Silengo MC; Ferrero GB
    Pediatr Res; 2014 Dec; 76(6):544-8. PubMed ID: 25167201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia.
    Clericuzio CL; Chen E; McNeil DE; O'Connor T; Zackai EH; Medne L; Tomlinson G; DeBaun M
    J Pediatr; 2003 Aug; 143(2):270-2. PubMed ID: 12970646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal hepatoblastoma in a newborn with severe phenotype of Beckwith-Wiedemann syndrome.
    Mussa A; Ferrero GB; Ceoloni B; Basso E; Chiesa N; De Crescenzo A; Pepe E; Silengo M; de Sanctis L
    Eur J Pediatr; 2011 Nov; 170(11):1407-11. PubMed ID: 21448630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum alpha-fetoprotein screening for hepatoblastoma in Beckwith-Wiedemann syndrome.
    Mussa A; Ferrero GB
    Am J Med Genet A; 2017 Mar; 173(3):585-587. PubMed ID: 28211991
    [No Abstract]   [Full Text] [Related]  

  • 5. The utility of alpha-fetoprotein screening in Beckwith-Wiedemann syndrome.
    Duffy KA; Deardorff MA; Kalish JM
    Am J Med Genet A; 2017 Mar; 173(3):581-584. PubMed ID: 28160403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Monitoring of Alpha-Fetoprotein by Dried Blood Spot for Hepatoblastoma Screening in Beckwith⁻Wiedemann Syndrome.
    Mussa A; Ciuffreda VP; Sauro P; Pagliardini V; Pagliardini S; Carli D; Kalish JM; Fagioli F; Pavanello E; Ferrero GB
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30646549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice.
    Tan TY; Amor DJ
    J Paediatr Child Health; 2006 Sep; 42(9):486-90. PubMed ID: 16925531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining an optimal time window to screen for hepatoblastoma in children with Beckwith-Wiedemann syndrome.
    Mussa A; Duffy KA; Carli D; Ferrero GB; Kalish JM
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27492. PubMed ID: 30270492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoblastoma in molecularly defined, congenital diseases.
    Nussbaumer G; Benesch M
    Am J Med Genet A; 2022 Sep; 188(9):2527-2535. PubMed ID: 35478319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoblastoma associated with Beckwith-Wiedemann syndrome and hemihypertrophy.
    Hamada Y; Takada K; Fukunaga S; Hioki K
    Pediatr Surg Int; 2003 Apr; 19(1-2):112-4. PubMed ID: 12721741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome.
    Everman DB; Shuman C; Dzolganovski B; O'riordan MA; Weksberg R; Robin NH
    J Pediatr; 2000 Jul; 137(1):123-7. PubMed ID: 10891834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital Hepatoblastoma and Beckwith-Wiedemann Syndrome.
    Zivot A; Edelman M; Glick R; Hong A; Fish JD
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):e798-e800. PubMed ID: 31335825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.
    Fiala EM; Ortiz MV; Kennedy JA; Glodzik D; Fleischut MH; Duffy KA; Hathaway ER; Heaton T; Gerstle JT; Steinherz P; Shukla N; McNeer N; Tkachuk K; Bouvier N; Cadoo K; Carlo MI; Latham A; Dubard Gault M; Joseph V; Kemel Y; Kentsis A; Stadler Z; La Quaglia M; Papaemmanuil E; Friedman D; Ganguly A; Kung A; Offit K; Kalish JM; Walsh MF
    Cancer; 2020 Jul; 126(13):3114-3121. PubMed ID: 32320050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: a cost-effective model.
    McNeil DE; Brown M; Ching A; DeBaun MR
    Med Pediatr Oncol; 2001 Oct; 37(4):349-56. PubMed ID: 11568898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DLK1, a serum marker for hepatoblastoma in young infants.
    Falix FA; Aronson DC; Lamers WH; Hiralall JK; Seppen J
    Pediatr Blood Cancer; 2012 Oct; 59(4):743-5. PubMed ID: 22180200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living donor liver transplantation for hepatoblastoma with Beckwith-Wiedemann syndrome.
    Sasaki K; Kasahara M; Fukuda A; Shigeta T; Tanaka H; Nakagawa S; Mitsui K; Harada R; Nakagawa A
    Pediatr Transplant; 2010 Nov; 14(7):E89-92. PubMed ID: 19496980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The overlap between Sotos and Beckwith-Wiedemann syndromes.
    Mussa A; Chiesa N; Porta F; Baldassarre G; Silengo MC; Ferrero GB
    J Pediatr; 2010 Jun; 156(6):1035-1036. PubMed ID: 20394943
    [No Abstract]   [Full Text] [Related]  

  • 18. Nested stromal epithelial tumor of the liver in Beckwith-Wiedemann syndrome.
    Malowany JI; Merritt NH; Chan NG; Ngan BY
    Pediatr Dev Pathol; 2013; 16(4):312-7. PubMed ID: 23570373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the Serum α-Fetoprotein Reference Range in Patients with Beckwith-Wiedemann Spectrum.
    Duffy KA; Cohen JL; Elci OU; Kalish JM
    J Pediatr; 2019 Sep; 212():195-200.e2. PubMed ID: 31235384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse surveillance in AFP-positive hepatoblastoma: re-evaluating the role of imaging.
    Rojas Y; Guillerman RP; Zhang W; Vasudevan SA; Nuchtern JG; Thompson PA
    Pediatr Radiol; 2014 Oct; 44(10):1275-80. PubMed ID: 24839140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.